Its often about trial and adjustment under medical supervision
Your patient is suffering from chronic granulomatous disease (CGD) which results in recurrent bouts of infection
J Cell Physiol (2020) 235(2):97992
We also wish to thank Peter Ravn (MedImmune Ltd, Cambridge, UK) for intellectual input into GLP-1 analogue peptide stabilization, Bojana Popovic and Daniel Cannon (MedImmune Ltd, Cambridge, UK) for generating and analysing the peptide homology model, Adrian Podmore (MedImmune Ltd, Cambridge, UK) for conducting the aggregation and stability testing, Richard Kay (LGC, Fordham, UK) for conducting the mass spectrometry metabolites identification work, Marcella Petrone and John Hood (MedImmune Ltd, Cambridge, UK) for performing PK-PD simulations and analysis as well as Christopher Rhodes (MedImmune LLC, Gaithersburg, MD, USA) for his critical review of this manuscript
We look at your medical history, talk about your goals, and decide together if its a good fit
Yes it is really challenging task...we need to appreciate DRL to take this high level game
